Loews Corporation to Release Second Quarter 2020 Results on August 3, 2020
- Tesla lifts Nasdaq to record-high close, S&P 500 dips
- Bitcoin (BTC) Recovers to $34,000 as Analysts Insists Crypto Winter Won't Repeat Again
- Dollar edges higher as Fed debate over inflation continues
- Cathie Wood's ARK Buys ~$77M in Bitcoin-Related Securities Yesterday on Dip
- Microsoft (MSFT) Price Target Raised to 'Street High' $325 at Wedbush as Cloud Story Is Not Slowing Down
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
NEW YORK, July 16, 2020 /PRNewswire/ -- Loews Corporation (NYSE: L) will report second quarter 2020 financial results on Monday, August 3, 2020. The conference call for investors will begin at 10:00 a.m. ET and will be hosted by the Company's chief executive officer, James S. Tisch, and chief financial officer, David B. Edelson.
Loews invites shareholders to submit questions for management in advance of this conference call. Management may address some or all these questions during the call. Questions may be submitted to email@example.com. Contributors of questions will not be named on the call.
The news release and a live webcast of the conference call will be available online at the Loews Corporation website (www.loews.com). Those interested in participating should dial (877) 692-2592, or for international callers, (973) 582-2757. The conference ID number is 7997145.
A replay of the call will be available at www.loews.com or by dialing (855) 859-2056, or for international callers, (404) 537-3406. The telephone replay requires conference ID number 7997145 and will be available through September 8th, 2020.
About Loews Corporation
Loews Corporation is a diversified company with businesses in the insurance, energy, hospitality and packaging industries. For more information please visit www.loews.com.
SOURCE Loews Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The investor who incorporates altruism into the business model
- Best Solar Stocks to Invest in 2021? Wall Street Weighs In
- FDA grants Breakthrough Therapy designation for lecanemab in Alzheimer's disease
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!